Clinical Trial Update: Long-term Treatment on BAY77-1931 (Lanthanum Carbonate) to Measure Lanthanum Concentrations in Bone [Phase 2]

View source ↗

Summary

Phase 2 study evaluating long-term lanthanum carbonate treatment in hyperphosphatemia patients on dialysis to measure lanthanum concentrations in bone. The tria…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Hyperphosphatemia

Drugs mentioned

• LANTHANUM CARBONATE (lanthanum carbonate)

Snippet

Sponsor: Bayer | Conditions: Hyperphosphatemia, Dialysis | Phase 2 | Status: COMPLETED